-+ 0.00%
-+ 0.00%
-+ 0.00%

Jade Biosciences Q3 EPS $(0.42) Beats $(0.71) Estimate

Benzinga·11/13/2026 12:08:21
Listen to the news
Jade Biosciences (NASDAQ:JBIO) reported quarterly losses of $(0.42) per share which beat the analyst consensus estimate of $(0.71) by 40.85 percent. This is a 12.5 percent increase over losses of $(0.48) per share from the same period last year.